Advertisement

Reactions Weekly

, Volume 1729, Issue 1, pp 51–51 | Cite as

Bevacizumab/lapatinib/temozolomide

Drug resistance: case report
Case report
  • 22 Downloads

Reference

  1. Miller CA, et al. Resistance-promoting effects of ependymoma treatment revealed through genomic analysis of multiple recurrences in a single patient. Cold Spring Harbor Molecular Case Studies 4: No. 2, 2 Apr 2018. Available from: URL: http://doi.org/10.1101/mcs.a002444 - USA

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations